Event
BHBIA Winter Seminar 2024: Unlocking Tomorrow: Exploring the Future of UK Business Insights and Your Strategic Advantage
IET London: Savoy Place
Friday 06 December 2024, 09:45-16.30
The UK healthcare landscape is undergoing a profound transformation, driven by a broken system, a change in government and significant changes in health policy. As business insights professionals, we face a similar onslaught of change, including the explosion of data sources, the rise of AI, evolving data governance policies, the threat of offshoring, and more—all against the backdrop of a volatile UK and global economy.
Whilst the changing environment brings challenges, it also presents opportunities. How can we, as individuals and as a community, stay at the forefront of business insights? Where should we focus our efforts? What are the distractions that might hinder our progress?
Join us at this year's Winter Seminar to explore the future of healthcare and business intelligence in the UK. Together, let's discuss how we can position ourselves and set up for success as a thriving community of business insights professionals.
09:45 Registration & Tea / Coffee
10:20 Welcome and introduction
10:25 The Nine for 2025 – Future Global & UK Market Trends and How the Business Insights Professional Needs to Adapt
Sarah Rickwood, Vice President, EMEA Thought Leadership - IQVIA
This session will outline nine key issues shaping the healthcare industry in 2025. From environmental factors to technological advancements, these trends will influence how business insights professionals need to adapt to rapid change. The speakers will explore emerging trends in healthcare, pharmaceuticals, patient care and the UK market dynamics.
10:55 Payer & Pharmacy Perspectives – What Lies Ahead?
Omar Ali, Former
Adviser to NICE & Visiting Lecturer Value Based Pricing & Head of
Payers - Verpora
Adam Buckler, Vice President, Innovative Contracting - Verpora
This session covers the outlook from both payers and pharmacists:
- Payer Perspectives: Omar Ali will consider how aligning with payers to demonstrate value is crucial for pricing strategies, discuss overcoming the mismatch between cost and perceived value, and explore whether rare disease/orphan drug pricing is sustainable.
- Pharmacy Perspectives: Adam Buckler will examine the role of pharmacy in the NHS, examining how data on prescribing and healthcare records is evolving and the opportunities these data linkages provide for business insights.
11:30 Tea / Coffee Break
11:50 New Government Health Policy Update & Impact on the Business Insight Professional
Paul Midgley, NHS Insight Specialist, Member of NHS Nottinghamshire ICB, Digital & Social Inclusion Board - Digital Strategy Oversight Group
Paul Midgley will provide an in-depth review of new government health policies and their impact on the customer environment. This session will cover how policy changes affect customer targeting and segmentation, resource allocation and market research.
12:40 The Skills, Behaviours & Capabilities Required to Unlock Your Future Strategic Advantage
Daniel Ghinn, CEO and Founder - CREATION.co
Paul O'Nions, Founder - GTMx Consulting Ltd.
Sarah Rickwood, Vice President, EMEA Thought Leadership - IQVIA
In this panel discussion, industry leaders will address the key skills and capabilities business insights professionals need to maintain a strategic edge. Topics will likely include the UK’s strategic role, market fluctuations, system readiness and the transformations in marketing and business insights arising from new technologies.
13:15 BHBIA Board Announcements
13:35 Drinks reception followed by Christmas lunch
Speaker Details
A pharmacist payer with over 15 years experience across both primary care & secondary care having served on numerous formulary groups, drugs & therapeutics & area prescribing committees. Omar has been a visiting Lecturer at UCLH Pharmacy Programme and was both Lecturer & Examiner on Independent Prescribing the University of Surrey He has over 30 publications to date was an Editorial Content Adviser to Guidelines, and Associate Editor to the Canadian Journal of Population Therapeutics & Clinical Pharmacology.
Omar has served a position on the External Reference Group on Cost Impact Modelling for NICE for 10 years was also appointed Panel Member for the newly formed Adoption & Impact Program Reference for NICE thereafter. He has advised foreign investors (US Embassy) on ‘Value Based Assessments (hosted by the UKDTi).
As head of payers at Verpora, he leads a group of 150 global payers within a network bringing pricing, access & reimbursement expertise from over 30 markets across the globe. He has embarked on a PhD doctorate on Value-based & innovative contracting with medicines publishing his 1st thesis “Performance based leasing model over time for CAR-T therapies” commissioned by Catapult & NHS England. He is a well-seasoned global speaker, most recently having delivered the keynote at AMCP New Orleans, guest speaker at Model-N Austin Texas, presenting at Italian Healthcare Senato della Republica in Rome and on Evaluation and Sustainability models of Healthcare at Future of Pharmacy Commissioning at London Houses of Parliament.
Adam is an accomplished pharmacist with over 12 years of NHS experience in acute Trusts and at The Royal Marsden NHS Foundation Trust, a prestigious oncology and haematology centre. His expertise spans Electronic Prescribing & Medicines Administration (EPMA) and Education & Training (E&T), with a deep understanding of NHS data systems, processes and capabilities. During his NHS tenure, Adam also contributed to the NHSE and NIHR Electronic-Prescribing Toolkit.
Currently, Adam leads the Innovative Contracting business unit at Verpora, where he oversees a team of healthcare researcher analysts dedicated to tracking global activity and advancements in Innovative Contracting. In his role, he works closely with pharmaceutical companies, designing value-based contracts that enhance access to vital medications or deliver contracting capability-building programs to upskill market access teams. Leveraging his background in EPMA and NHS data, Adam also provides critical clinical and healthcare insights for Verpora’s VSTx product.
Paul Midgley is an experienced leader in the UK NHS and life sciences sectors, passionate about accelerating NHS transformation. Beginning his career at GSK, Paul moved to found Healthcare Partnership in 2001, guiding pharma and medtech in NHS engagement. His NHS insight led to NHS board roles, including Community Director in an innovative CIC. Paul currently sits on 8 NHS committees and Boards.
After Healthcare Partnership's acquisition by NHiS Ltd, Paul became Director of NHS Insight, developing the organisation’s reputation for NHS expertise and improving outcomes through insights. He then became Director of NHS Insight at Wilmington Healthcare, working with big pharma and medtech UK affiliates to help accelerate market access and leading Wilmington’s Thought Leadership practice.
In 2023, Paul launched Paul Midgley Associates Limited, offering strategic NHS insight to clients working with the NHS, supporting sustainable, patient-centred solutions across pharma, medtech and digital health sectors.
Daniel Ghinn, founder of insights consultancy CREATION.co, has been at the forefront of studying healthcare professionals’ (HCPs) digital media engagement since 1998. In his book, Activating Digital Opinion Leaders, he outlines a methodology for identifying, engaging, and empowering influential HCPs on social media. Daniel's pioneering work led to the launch of CREATION Pinpoint, an AI-driven platform that monitors millions of HCPs on social media, spotlighting the most influential voices within their networks. Today, he is spearheading the development of a new app that helps HCPs track and enhance their own social media impact. Daniel's mission at CREATION.co is to drive positive health outcomes and transform nations through meaningful healthcare insights.
Paul has over two decades of experience in the pharmaceutical industry, where he is known for driving innovation and excellence in business intelligence. As a catalyst in this field, he has served on the board of the British Healthcare Business Intelligence Association (BHBIA) since 2015 and has been Chair since 2020. His career includes leadership roles at Sanofi and Novo Nordisk, where he led projects in CRM, analytics, and key account management. He also supported NHS England during the COVID-19 pandemic, applying data-driven strategies to support critical supply challenges. In 2024, Paul founded GTMx Consulting, leveraging his rich experience to empower health systems and deliver next-generation commercial solutions.
Delegate Fees
This event is open only to BHBIA full members.
Early bird' delegate fees for bookings made on or before 8th November 2024:
Members: £350 + VAT
(These prices include an early booking discount).
Cancellation Policy for early bird bookings: full fee payable / no refunds given; however a substitute delegate can be accepted. (Our standard cancellation policy does not apply).
Delegate Fees for bookings made after 8th November 2024:
Members: £390 + VAT
Cancellation Policy: standard cancellation policy applies, as stated on booking form
VAT will be added when you click Register for Event
Venue accessibility - At IET London: Savoy Place full disabled access is available to the event rooms and public facilities. Please click here for further information or contact admin@bhbia.org.uk.